A research study to explore the impact of GP support via text messages to patients with asthma and/or chronic obstructive pulmonary disease
Asthma and chronic obstructive pulmonary disease (COPD) are common lung conditions in the UK. Daily preventer inhalers help keep airways clear and stop flare-ups, but it is easy to forget to use them regularly. Researchers want to see if helpful text messages from a person's GP surgery can make a positive difference. In this six-month study, adults with asthma or COPD who use preventer inhalers are put into two groups by chance. One group receives their usual GP care. The other group gets their usual care plus supportive text messages containing reminders and advice on managing their condition. All participants will answer three short surveys online during the study to track their symptoms and medicine habits. The goal is to discover simple, low-cost ways for the NHS to help people look after their lungs.
At a glance
What is this study about?
Asthma and COPD affect millions of people across the UK, causing symptoms such as breathlessness, wheezing, and coughing. Doctors prescribe preventer inhalers to protect the lungs and stop flare-ups before they start. However, studies show that around half of all people with long-term health conditions do not take their medicines as prescribed. When life gets busy or symptoms feel quiet, it is easy to forget a daily dose.
This research project, developed with NHS communications partner Accurx, is testing a simple, digital solution. The researchers want to find out whether friendly, helpful text messages sent directly from a patient's GP practice can help people stick to their daily inhaler routine and keep their breathing symptoms under better control.
Finding low-stress ways to support lung health could make a major difference. Taking preventer inhalers regularly can mean fewer sudden attacks, less time off work, and fewer emergency trips to the hospital. By checking whether text reminders truly improve medicine habits, this study could help the NHS design better, more personal support for people living with lung conditions.
Key takeaways
- Tests whether GP text messages help people remember to use daily preventer inhalers.
- Open to adults in England with asthma or COPD who have a mobile phone.
- Lasts for 26 weeks and requires no hospital or clinic visits.
- Participants complete three short surveys about their breathing and medicine use.
- Your regular medical care and prescriptions do not change.
Who may be eligible?
You may be able to join this study if you are 18 or older and live in England, registered at a participating GP surgery. You must have an official diagnosis of asthma, COPD, or both, recorded in your GP medical notes, and you must currently be prescribed a daily preventer inhaler.
Because the study is delivered digitally, you will need your own mobile phone. You must be able to receive and read standard text messages, and you need to be comfortable completing short questionnaires in English.
People who do not have access to a mobile phone, cannot read text messages, or feel unable to complete the short study questionnaires will not be able to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you aged 18 or older?
- Has a doctor diagnosed you with asthma, COPD, or both?
- Do you currently have a prescription for a daily preventer inhaler?
- Do you have a mobile phone and can you open and read text messages?
- Are you registered with a GP surgery in England that is taking part in the study?
What does participation involve?
Taking part lasts for 26 weeks (about six months) and is done entirely from your home using your mobile phone. You will not need to attend extra clinic appointments or change your regular inhalers.
After signing up, a computer puts you into one of two groups by chance, like flipping a coin. If you are in the text message group, you will receive helpful text reminders and tips from your GP surgery over six months alongside your usual care. If you are in the comparison group, you will continue your usual GP care without the study texts.
Everyone in both groups will complete three short online surveys: one at the start (week 1), one halfway through (week 13), and one at the end (week 26). These ask about your breathing symptoms, how often you use your inhaler, and any NHS services you used. Researchers will also look at your routine prescription requests to see if text reminders helped people collect their medicines on time.
Potential risks and benefits
Locations (1)
- 87 GP practices across England are participating in this trialCity only-, England
Common questions
Will taking part change my current inhalers or prescriptions?
No. You will keep taking your usual preventer inhaler and any other medicines prescribed by your doctor.
Do I have to travel to my GP surgery or a hospital for visits?
No. The entire study happens via text message and online surveys, so you can take part from anywhere.
Does it cost anything to receive the study text messages?
No. Receiving text messages from your GP surgery is completely free.
Can I choose whether I receive the text messages?
No. A computer places participants into either the text group or the usual care group by chance to keep the results fair and reliable.
What happens if I decide I want to stop taking part?
You can leave the study at any point by following the opt-out instructions, and your normal GP care will stay exactly the same.
How to find out more
Victoria Fussey
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.